A phase III, investigator blind, randomized, multicenter study to evaluate the efficacy and safety of APC-231 [amoxicillin] sprinkle QD for 7 days vs penicillin VK [phenoxymethylpenicllin potassium] 10 mg/kg QID for 10 days in pediatric patients with Streptococcus pyogenes
Latest Information Update: 29 Sep 2005
At a glance
- Drugs Amoxicillin (Primary) ; Phenoxymethylpenicillin potassium
- Indications Pharyngitis; Streptococcal infections; Tonsillitis
- Focus Therapeutic Use
- 29 Sep 2005 New trial record.